Clinical Cases in Pharmacology Clinical Cases  ·  Cardiovascular  ·  Valvular Disease  ·  Aortic Stenosis and Mitral Regurgitation Together: Two Patients, Discordant Severity
Cardiovascular, Case 0183 — Valvular Disease

Aortic Stenosis and Mitral Regurgitation Together: Two Patients, Discordant Severity

Two patients each carry a stenotic aortic valve and a leaking mitral valve at the same time, but in neither case do the two lesions carry equal weight. The disagreement in each case is about which valve is actually driving symptoms and risk, and whether treating it changes how the other one should be read.

Abbreviations, terms, and other agents mentioned in this case AS — aortic stenosis  ·  MR — mitral regurgitation  ·  LV — left ventricle  ·  EF — ejection fraction  ·  AF — atrial fibrillation  ·  TAVR — transcatheter aortic valve replacement  ·  Low-flow, low-gradient AS — a genuinely severe valve whose measured gradient reads low because the ventricle isn't driving enough volume across it; defined by a valve area under 1.0 cm² with a mean gradient under 40 mmHg
Presentation
Case A

W.H., a 74-year-old man, has kept the same vegetable beds behind his house for over twenty years, and it was his wife, not any symptom he'd have reported on his own, who noticed he'd stopped working them past twenty minutes at a stretch this summer — he used to go two hours without stopping. He has known moderate aortic stenosis for three years, followed on yearly echocardiograms that never quite crossed into severe range, and long-standing hypertension that has never been especially well controlled despite two medications. This year's echo added something new: moderate mitral regurgitation, of the secondary type, arising not from any problem with the mitral valve itself but from a left ventricle that has spent years working against both his stiffened aortic valve and his blood pressure, remodeling in ways that let the mitral leaflets stop coapting as tightly as they should.

The two findings are not necessarily independent facts sitting side by side; they may be one mechanism read twice. If the aortic valve's afterload burden is what stretched the ventricle enough to loosen the mitral valve, the real question isn't which valve to fix first, but whether fixing the aortic valve — even at a severity still formally called moderate — might correct the mitral regurgitation on its own, the way secondary MR is known to improve when its underlying driver resolves. His numbers do not leave room for the usual escape hatch: a dobutamine study exists to unmask a severe valve hiding behind a weak ventricle, and it applies only when the valve area is already under 1.0 square centimeter with a mean gradient under 40 and an ejection fraction under 50 percent. His valve area is 1.3 and his ejection fraction is 55, so the stenosis is moderate as measured, not moderate by artifact. What is genuinely unresolved is whether his symptoms belong to that moderate valve at all — a question an exercise stress echocardiogram can address, by documenting how far he actually gets, and by showing whether the gradient and the mitral regurgitation climb steeply under load or stay where they sit at rest.

Patient A · W.H. Index Case
History
Moderate AS known 3 years; new moderate secondary MR this year
Symptoms
New exertional dyspnea and fatigue; stopped keeping up with gardening
Mechanism
Secondary MR attributed to LV remodeling from long-standing hypertension and AS afterload
Hemodynamics
AS: mean gradient 32 mmHg, valve area 1.3 cm² (moderate); MR: moderate, functional
Blood pressure
158/92 despite two agents
LV function
EF 55%, mild concentric hypertrophy
Comorbidities
Hypertension (poorly controlled), hyperlipidemia

Case A — At the bedside

Cardiologist Opening

I'd get an exercise stress echo before deciding anything about his mitral valve — not a dobutamine study, which is for the low-flow, low-gradient picture he doesn't have. His secondary regurgitation is very likely downstream of afterload burden, whichever way the true aortic severity turns out to read — and treating the mitral valve directly, when it isn't the primary problem, risks fixing the wrong lesion.

Cardiothoracic Surgeon Response

Agreed on getting better hemodynamic data first, but there's a practical surgical point worth raising now rather than later. If he ends up needing aortic valve replacement — whether his valve progresses to severe, or an exertional study reclassifies where his symptoms are coming from — and I'll grant that symptomatic moderate stenosis is not itself an indication to replace the valve; that question is being tested in trials and isn't settled guidance yet — the secondary MR should be reassessed intraoperatively, not assumed away beforehand. Functional MR doesn't always fully resolve once its primary driver is corrected, especially after years of remodeling, and being unprepared to address it in the same operation means sending him back for a second one later if it persists.

Clinical Pharmacologist Final

His hypertension is a real, independently correctable contributor here, separate from either valve. More aggressive antihypertensive optimization is worth doing now regardless of what the stress echo shows — he's on two agents and still well above goal — both because tighter control may itself reduce the secondary MR's severity, and because uncontrolled afterload will confound interpretation of any stress test performed while his pressure remains this high.

Regimen selected
Amlodipine (added)
Calcium Channel Blocker · Added
Targets his above-goal blood pressure directly; may also reduce the secondary MR's severity by lowering afterload independent of any valve procedure.
Empiric Mitral Valve Repair
Ruled Out
Not pursued directly; the working hypothesis is that his mitral regurgitation is downstream of afterload physiology rather than a primary mitral problem needing its own repair.
Where this was left

Agreed: exercise stress echocardiography to clarify how much of his symptom burden the moderate aortic valve actually accounts for, blood pressure optimization intensified regardless of the stress test's outcome.

Not agreed, and the reason the mitral valve's fate stayed genuinely open:

If the stress echo shows a steep exertional gradient rise and clear symptom limitation

Shortened surveillance with a low threshold for aortic valve replacement once severity criteria are met, and reassessment of the mitral regurgitation at that point rather than on its own.

If exercise capacity is preserved and the gradient behaves

Continue surveillance of both valves, treating blood pressure as the primary modifiable driver in the meantime.

The pivot · Case B shares the same discordant anatomy — but here the mitral valve, not the aortic valve, is what changed
Case B

L.F., a 68-year-old woman, has spent thirty years on a hospital nursing floor without ever being the patient in the bed, which made it strange enough that she mentioned it to her own cardiologist almost as a joke — new palpitations partway through a shift, and a breathlessness walking the hallway that had nothing to do with how busy the floor was that day. She has known paroxysmal atrial fibrillation for two years, well controlled on apixaban, and a moderate aortic valve narrowing that has sat unchanged on three consecutive years of imaging. What's new this year is her mitral valve: a prolapsing posterior leaflet, degenerative rather than functional, now regurgitating severely by every echocardiographic criterion the lab uses.

Unlike a mitral valve that leaks because a ventricle has stretched around it, hers is the primary problem — the leaflet itself has failed mechanically, independent of anything happening elsewhere in her heart — and her new symptoms, the palpitations and the volume-type breathlessness, track that lesion specifically rather than the pattern a worsening aortic valve would produce. Her aortic stenosis, stable for three years running, isn't the thing that changed, and nothing in her recent decline points back to it. She has already cut her nursing shifts to part-time rather than push through the fatigue, a concession she says she resents making. The question in front of her surgical team isn't really which valve is driving her symptoms — that part reads clearly — it's whether her stable, moderate aortic valve should be addressed in the same operation as the mitral repair, or left alone and simply watched.

Patient B · L.F. Comparative Case
History
Paroxysmal AF (2 years, on apixaban); new severe primary MR this year
Symptoms
New palpitations, exertional dyspnea; cut clinical shifts to part-time
Mitral mechanism
Degenerative, posterior leaflet prolapse; eccentric jet, severe by criteria
Aortic valve
Moderate AS, mean gradient 28 mmHg, unchanged over 3 years
Rhythm
Paroxysmal AF, rate-controlled, on apixaban
LV size
Mild dilation consistent with volume-loaded MR
Comorbidities
None beyond AF; otherwise active, works per-diem nursing shifts
What makes L.F.'s picture categorically different from W.H.'s
Her aortic valve, unlike his, has been stable for three straight years, and her symptom pattern — new atrial fibrillation, volume-type breathlessness — tracks the mitral lesion specifically, not the afterload-driven presentation that would implicate the aortic valve instead.

Case B — At the bedside

Cardiothoracic Surgeon Opening

I'd favor a combined single operation: repair the mitral valve — technically feasible, since degenerative pathology like hers is typically repairable — and address the aortic valve in the same setting. Operating on a moderate aortic valve while an open mitral operation is already planned carries little incremental risk compared to a second operation years from now if her AS eventually progresses, and it avoids reoperative risk altogether.

Cardiologist Response

Her aortic valve is genuinely stable, moderate, and asymptomatic in its own right. Replacing a moderate valve during another cardiac operation is a weak, conditional recommendation — reasonable to consider, not something the guideline directs — and adding an aortic procedure she has no independent indication for to an operation that doesn't otherwise need one increases cross-clamp time and procedural risk for a valve that may never need treatment in her lifetime. I'd favor mitral repair alone, with continued surveillance of the aortic valve on its own timeline.

"Little incremental risk" still isn't zero risk, and it's being added for a lesion that today gives her no reason to need it.

Interventional Cardiologist Final

Worth naming the option that actually lowers the cost of waiting: if her aortic valve does eventually progress, her anatomy and the fact that a separate mitral operation won't complicate a future transcatheter approach the way it might complicate a future surgical one make her a strong future TAVR candidate. Watchful waiting on the aortic valve today doesn't foreclose a good option later — it just defers a decision that isn't needed yet.

Regimen selected
Apixaban (continued)
Factor Xa Inhibitor · Ongoing for Paroxysmal AF
Held preoperatively and resumed once surgical hemostasis allows, rather than carried through the operation; her stroke risk from atrial fibrillation is unchanged by valve surgery. A repair with an annuloplasty ring does not force a switch to warfarin, though some centers still use a vitamin K antagonist for the first three months after mitral repair.
Empiric Aortic Valve Intervention
Ruled Out
Not indicated; her aortic stenosis is stable, moderate, and asymptomatic on its own criteria.
Where this was left

Agreed: mitral valve repair planned; her aortic valve left untouched at this operation, given its stability and a concomitant-AVR recommendation that's real but only conditional — Class 2a, not mandatory.

Not agreed, and the reason her aortic valve's future stayed an open question rather than a closed one:

If her AS eventually progresses to severe

A transcatheter approach is favored, given her anatomy and the absence of any complication a prior sternotomy would otherwise raise.

If her AS remains stable long-term

No further aortic intervention is ever needed; today's mitral repair remains a one-time, single-valve operation.

Educational content only — a composite teaching case, not a real patient encounter or a substitute for clinical guidance. About These Cases →